• 56
  • 9
  • 收藏

Merck raises full-year profit target after cancer drug sales help Q3 beat

Reuters2021-10-28

(Reuters) -Merck & Co Inc raised its full-year adjusted profit forecast on Thursday, after strong demand for its blockbuster cancer drug Keytruda and recovery in sales of its non-COVID-19 vaccines ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论9

  • PKsummer
    ·2021-10-29
    Hope your covid19 drug will adapted by whole world then share price rocket to the Mar., [财迷] 
    回复
    举报
  • Cyberkien
    ·2021-10-28
    🚀🚀🚀
    回复
    举报
    收起
    • Felicialim
      🍇🥥🪨🪨😍
      2021-10-28
      回复
      举报
  • koolgal
    ·2021-10-28
    Merck would be ending on a high note in view of its raised profit forecast.  Nice work Merck! 
    回复
    举报
    收起
    查看更多 2 条评论
  • hotwheels
    ·2021-10-28
    Merck and Biotherapeutics have applied for emergency use authorization of the drug, which could potentially change how COVID-19 is treated.
    回复
    举报
  • BoonHuat
    ·2021-10-28
    Nice.
    回复
    举报
  • kdcc
    ·2021-10-28
    Like pls.. Thanks.. 
    回复
    举报
    收起
    • JeremyKok
      hi. please like and comment back. thank you.
      2021-10-29
      回复
      举报
    • kdcc
      Thanks
      2021-10-28
      回复
      举报
    • Dazhu
      ok
      2021-10-28
      回复
      举报
    查看更多 2 条评论
  • Soe77
    ·2021-10-28
    Ho say liaoz!
    回复
    举报
  • Valeriechan
    ·2021-10-28
    [Cool] 
    回复
    举报
    收起
  • Tck
    ·2021-10-28
    [龇牙] 
    回复
    举报
    收起
    • Tck
      g
      2021-10-28
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24